Melanoma Clinical Trials in Grenoble
2 recruitingGrenoble, France
Showing 1–2 of 2 trials
Recruiting
Not Applicable
Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy
Lung CancerMelanomaRenal Cancer
Hospices Civils de Lyon100 enrolled10 locationsNCT04605146
Recruiting
Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients
Melanoma
University Hospital, Grenoble707 enrolled1 locationNCT06154668